291 related articles for article (PubMed ID: 24173241)
1. Role of Angptl4 in vascular permeability and inflammation.
Guo L; Li SY; Ji FY; Zhao YF; Zhong Y; Lv XJ; Wu XL; Qian GS
Inflamm Res; 2014 Jan; 63(1):13-22. PubMed ID: 24173241
[TBL] [Abstract][Full Text] [Related]
2. ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2.
Gomez Perdiguero E; Liabotis-Fontugne A; Durand M; Faye C; Ricard-Blum S; Simonutti M; Augustin S; Robb BM; Paques M; Valenzuela DM; Murphy AJ; Yancopoulos GD; Thurston G; Galaup A; Monnot C; Germain S
J Pathol; 2016 Dec; 240(4):461-471. PubMed ID: 27577973
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.
Xin X; Rodrigues M; Umapathi M; Kashiwabuchi F; Ma T; Babapoor-Farrokhran S; Wang S; Hu J; Bhutto I; Welsbie DS; Duh EJ; Handa JT; Eberhart CG; Lutty G; Semenza GL; Montaner S; Sodhi A
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3425-34. PubMed ID: 23959876
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of angiopoietin-like 4 on the blood-brain barrier in acute ischemic stroke treated with thrombolysis in mice.
Zhang B; Xu X; Chu X; Yu X; Zhao Y
Neurosci Lett; 2017 Apr; 645():113-120. PubMed ID: 28267563
[TBL] [Abstract][Full Text] [Related]
5. A review of the multifunctionality of angiopoietin-like 4 in eye disease.
Yang X; Cheng Y; Su G
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30049845
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma.
Katanasaka Y; Kodera Y; Kitamura Y; Morimoto T; Tamura T; Koizumi F
Mol Cancer; 2013 Apr; 12():31. PubMed ID: 23617883
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiopoietin-like protein 4 on rat pulmonary microvascular endothelial cells exposed to LPS.
Wang Y; Chen H; Li H; Zhang J; Gao Y
Int J Mol Med; 2013 Sep; 32(3):568-76. PubMed ID: 23783408
[TBL] [Abstract][Full Text] [Related]
8. Alteration of developmental and pathological retinal angiogenesis in angptl4-deficient mice.
Perdiguero EG; Galaup A; Durand M; Teillon J; Philippe J; Valenzuela DM; Murphy AJ; Yancopoulos GD; Thurston G; Germain S
J Biol Chem; 2011 Oct; 286(42):36841-51. PubMed ID: 21832056
[TBL] [Abstract][Full Text] [Related]
9. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma.
Ma T; Jham BC; Hu J; Friedman ER; Basile JR; Molinolo A; Sodhi A; Montaner S
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14363-8. PubMed ID: 20660728
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness.
Galaup A; Cazes A; Le Jan S; Philippe J; Connault E; Le Coz E; Mekid H; Mir LM; Opolon P; Corvol P; Monnot C; Germain S
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18721-6. PubMed ID: 17130448
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters.
Huang RL; Teo Z; Chong HC; Zhu P; Tan MJ; Tan CK; Lam CR; Sng MK; Leong DT; Tan SM; Kersten S; Ding JL; Li HY; Tan NS
Blood; 2011 Oct; 118(14):3990-4002. PubMed ID: 21841165
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like 4: A double-edged sword in atherosclerosis and ischemic stroke?
Xu L; Guo ZN; Yang Y; Xu J; Burchell SR; Tang J; Zhang J; Xu J; Zhang JH
Exp Neurol; 2015 Oct; 272():61-6. PubMed ID: 26033474
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of angiopoietin-like 4 in human cancer.
Tan MJ; Teo Z; Sng MK; Zhu P; Tan NS
Mol Cancer Res; 2012 Jun; 10(6):677-88. PubMed ID: 22661548
[TBL] [Abstract][Full Text] [Related]
14. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
[TBL] [Abstract][Full Text] [Related]
15. Suppression of angiopoietin-like 4 reprograms endothelial cell metabolism and inhibits angiogenesis.
Chaube B; Citrin KM; Sahraei M; Singh AK; de Urturi DS; Ding W; Pierce RW; Raaisa R; Cardone R; Kibbey R; Fernández-Hernando C; Suárez Y
Nat Commun; 2023 Dec; 14(1):8251. PubMed ID: 38086791
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma.
Le Jan S; Amy C; Cazes A; Monnot C; Lamandé N; Favier J; Philippe J; Sibony M; Gasc JM; Corvol P; Germain S
Am J Pathol; 2003 May; 162(5):1521-8. PubMed ID: 12707035
[TBL] [Abstract][Full Text] [Related]
17. Dual role of ANGPTL4 in inflammation.
Zuo Y; He Z; Chen Y; Dai L
Inflamm Res; 2023 Jun; 72(6):1303-1313. PubMed ID: 37300585
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-like 4: a decade of research.
Zhu P; Goh YY; Chin HF; Kersten S; Tan NS
Biosci Rep; 2012 Jun; 32(3):211-9. PubMed ID: 22458843
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway.
La Paglia L; Listì A; Caruso S; Amodeo V; Passiglia F; Bazan V; Fanale D
PPAR Res; 2017; 2017():8187235. PubMed ID: 28182091
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis.
Okochi-Takada E; Hattori N; Tsukamoto T; Miyamoto K; Ando T; Ito S; Yamamura Y; Wakabayashi M; Nobeyama Y; Ushijima T
Oncogene; 2014 Apr; 33(17):2273-8. PubMed ID: 23686315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]